M&As this week: Ionisos, China Regenerative Medicine International, M3

21 September 2017 (Last Updated September 21st, 2017 18:30)

Ionisos has announced the acquisition of sterilisation solutions specialist Stermed.

Ionisos has announced the acquisition of sterilisation solutions specialist Stermed.

The acquisition strengthens the cold sterilisation specialist’s position in the market and expands its geographic position in southern France.

Both companies are based in France.

Chinese biotechnology company China Regenerative Medicine International Ltd plans to acquire a 20% share in Denmark-based image analysis software developer RetinaLyze A/S.

"The acquisition strengthens the cold sterilisation specialist’s position in the market and expands its geographic position in southern France."

M3 Inc plans to acquire Cosmotec Co Ltd for CNY1.06bn ($9.03m).

Both the entities involved in the acquisition are based in Japan.